Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Use financial data to refine your budget with practical steps that help identify waste and improve allocation. This intro explains a data-driven approach to smarter budgeting.
27,071 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
As markets digest a potential shift in leadership, the biggest test for any Fed chair may be broader than inflation. ...
Nu Holdings has fallen about 31% from its peak this year. This article breaks down the business, the pullbacks, and w...
Headlines promising simple truths about markets often mislead. This article shows how prices reflect many signals ove...
A senior comms exec says AI notetakers are moving from convenience to liability as governance gaps and confidential n...
The news that Innodata’s founder sold a large chunk of shares is sending ripples through the market. This article bre...
A widening trust gap is pushing American workers into siloed teams and news feeds. Executives are racing to rebuild d...
An insider move of 8,000 shares can raise questions for investors. This article breaks down what such a sale might si...
U.S. regulators have cleared broader access to Anthropic’s Mythos model after a brief regulatory stand-off over safet...
When a CHH executive exercises stock options and sells shares ahead of retirement, it can raise questions for investo...
A year of dramatic moves has put Dave (DAVE) on investors' radar. A newly disclosed $7 million stake from a prominent...
Mortgage lenders are shifting from deal-by-deal momentum to long-term advisory relationships, redefining growth in a ...